<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This overview of the Symposium and its organization includes a historical survey of the scientific literature in which the relationship of <z:chebi fb="56" ids="16716">benzene</z:chebi> exposure to the development of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and other <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow diseases</z:e>, including <z:hpo ids='HP_0011009'>acute</z:hpo> myeloid (myelogenous) <z:hpo ids='HP_0001909'>leukemia</z:hpo>, is described </plain></SENT>
<SENT sid="1" pm="."><plain>Previous conferences on the health effects of <z:chebi fb="56" ids="16716">benzene</z:chebi> are summarized </plain></SENT>
<SENT sid="2" pm="."><plain>The important role of the revised World Health Organization classification of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of the hematopoietic and lymphoid tissues in clarifying the specific diseases related to <z:chebi fb="56" ids="16716">benzene</z:chebi> exposure is emphasized </plain></SENT>
</text></document>